Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 7 hours ago
Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisatio
about 7 hours ago
Human medicines European public assessment report (EPAR): Hexacima, diphtheria, tetanus, pertussis (acellular...
ETF-stakeholders meeting on biodistribution of mRNA vaccines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 June 2026, 14:00 (CEST) to 26 June 2026, 17:30 (CEST)
about 8 hours ago
ETF-stakeholders meeting on biodistribution of mRNA vaccines, Online, European Medicines Agency, Amsterdam...
Human medicines European public assessment report (EPAR): Hexyon, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed), Date of authorisation:
about 7 hours ago
Human medicines European public assessment report (EPAR): Hexyon, diphtheria, tetanus, pertussis (acellular...
Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation: 02/12/2008, Revision: 23, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation...
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 14, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted)...
Fifth European Medicines Agency and Nuclear Medicines Europe bilateral meeting, Online, 14 June 2024
about 8 hours ago
Fifth European Medicines Agency and Nuclear Medicines Europe bilateral meeting, Online, 14...
Minutes - HMA-EMA joint Network Data Steering Group meeting - 21 May 2026
about 8 hours ago
Minutes - HMA-EMA joint Network Data Steering Group meeting - 21 May...
CVMP recommendations on limited market classification and eligibility for authorisation under Article 23
about 8 hours ago
CVMP recommendations on limited market classification and eligibility for authorisation under Article...
List of signals discussed at PRAC since September 2012
about 9 hours ago
List of signals discussed at PRAC since September 2012
Paediatric Committee (PDCO): 23-26 June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 June 2026 to 26 June 2026
about 9 hours ago
Paediatric Committee (PDCO): 23-26 June 2026, Online, European Medicines Agency, Amsterdam, the...
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 38, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation...